Bank of America’s Immune Design Corp. IMDZ Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2019
Q2 | – | Sell |
-10,290
| Closed | -$61K | – | 7695 |
|
|
2019
Q1 | $61K | Sell |
10,290
-36,668
| -78% | -$125K | ﹤0.01% | 6119 |
|
|
2018
Q4 | $61K | Buy |
46,958
+16,600
| +55% | +$28.8K | ﹤0.01% | 6144 |
|
|
2018
Q3 | $105K | Sell |
30,358
-16,396
| -35% | -$61.6K | ﹤0.01% | 5855 |
|
|
2018
Q2 | $212K | Buy |
46,754
+32,669
| +232% | +$130K | ﹤0.01% | 5380 |
|
|
2018
Q1 | $46K | Sell |
14,085
-9,331
| -40% | -$33K | ﹤0.01% | 6080 |
|
|
2017
Q4 | $91K | Buy |
23,416
+6,953
| +42% | +$37.9K | ﹤0.01% | 5788 |
|
|
2017
Q3 | $171K | Buy |
16,463
+3,940
| +31% | +$38.8K | ﹤0.01% | 5456 |
|
|
2017
Q2 | $122K | Sell |
12,523
-2,723
| -18% | -$19.1K | ﹤0.01% | 5532 |
|
|
2017
Q1 | $104K | Buy |
15,246
+8,418
| +123% | +$48.7K | ﹤0.01% | 5612 |
|
|
2016
Q4 | $37K | Buy |
6,828
+6,249
| +1,079% | +$44.1K | ﹤0.01% | 6072 |
|
|
2016
Q3 | $5K | Sell |
579
-843
| -59% | -$6.16K | ﹤0.01% | 6655 |
|
|
2016
Q2 | $12K | Buy |
+1,422
| New | +$17.7K | ﹤0.01% | 6451 |
|
|
2016
Q1 | – | Sell |
-3,507
| Closed | -$70K | – | 7785 |
|
|
2015
Q4 | $70K | Buy |
3,507
+3,467
| +8,668% | +$59.7K | ﹤0.01% | 5889 |
|
|
2015
Q3 | $0 | Sell |
40
-1,134
| -97% | -$21.2K | ﹤0.01% | 7801 |
|
|
2015
Q2 | $24K | Buy |
1,174
+1,158
| +7,238% | +$27.4K | ﹤0.01% | 6281 |
|
|
2015
Q1 | $0 | Buy |
+16
| New | +$418 | ﹤0.01% | 8174 |
|
|
2014
Q4 | – | Sell |
-129
| Closed | -$2K | – | 8450 |
|
|
2014
Q3 | $2K | Buy |
+129
| New | +$1.63K | ﹤0.01% | 7853 |
|
Bank of America's IMDZ Position: Q2 2019 in Review
Bank of America sold out of Immune Design Corp. (IMDZ) in Q2 2019, closing a stake of 10,290 shares — an estimated $61K sold.
Bank of America first reported a position in IMDZ in Q3 2014 and held it in 17 quarters. The position peaked at $212K in Q2 2018. 0 funds tracked by Wall St. Rank hold IMDZ as of Q2 2019.
- Bank of America reported no remaining Immune Design Corp. position as of Q2 2019 after selling out during the quarter.
- Bank of America sold 10,290 Immune Design Corp. shares in Q2 2019, an estimated $61K.
- Bank of America first reported a position in Immune Design Corp. in Q3 2014 and held it in 17 quarters.
- Bank of America's Immune Design Corp. position peaked at $212K in Q2 2018.
- 0 funds tracked by Wall St. Rank held Immune Design Corp. as of Q2 2019.
Based on Bank of America's 13F filing for Q2 2019, filed 14 Aug 2019.